XML 49 R30.htm IDEA: XBRL DOCUMENT v2.4.1.9
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2014
Summary of Significant Accounting Policies  
Schedule of Property Plant and Equipment Useful Lives

 

                                                                                                                                                                                    

Buildings

 

20 years

Building improvements

 

5 - 20 years

Software, machinery and equipment

 

1 - 15 years

 

Schedule of components of the calculations of basic and diluted earnings per share:

 

                                                                                                                                                                                    

 

 

Year Ended December 31,

 

 

 

2014

 

2013

 

2012

 

Numerator:

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common shareholders

 

$

(88,643,700

)

$

(62,790,800

)

$

(31,862,454

)

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

Denominator:

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding

 

 

159,228,815

 

 

76,436,408

 

 

34,376,427

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of dilutive potential common shares

 

                                                                                                                                                                                    

 

 

At December 31,

 

 

 

2014

 

2013

 

2012

 

Stock options outstanding

 

 

8,367,271 

 

 

4,703,326 

 

 

1,986,255 

 

Restricted stock outstanding

 

 

473,336 

 

 

650,002 

 

 

 

Common stock warrants(1)

 

 

4,219,442 

 

 

24,137,878 

 

 

9,421,008 

 

Preferred stock(2)

 

 

5,554,594 

 

 

10,972,859 

 

 

—  

 

​  

​  

​  

​  

​  

​  

Number of dilutive potential common shares

 

 

18,614,643 

 

 

40,464,065 

 

 

11,407,263 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  


(1)

In May 2011, the Company issued 7,128,563 warrants as part of an underwritten public offering. As a result of additional public offerings, and pursuant to the effect of the anti-dilution provisions of these warrants, the number of warrants increased to 22,995,365. Of the warrants issued in May 2011, 22,776,023 have been exercised as of December 31, 2014. In February 2013, the Company issued 23,637,500 warrants as part of an underwritten public offering. Of the warrants issued in February 2013, 23,637,400 were exercised as of December 31, 2014. In January 2014, the Company issued 4,000,000 warrants as part of an underwritten public offering. Of the warrants issued in January 2014, none have been exercised as of December 31, 2014. As of December 31, 2014, the remaining 4,219,442 warrants have a weighted average exercise price of $3.84.

(2)

The preferred stock amount represents the dilutive potential common shares of the Series C redeemable convertible preferred stock issued on May 16, 2013 based on the conversion price of the preferred stock as of December 31, 2014. Of the 10,431 preferred shares issued in May 2013, 5,200 had been converted to common stock as of December 31, 2014.